Intuitive Surgical, Inc. (ISRG) Receives Consensus Recommendation of “Buy” from Brokerages

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have received an average recommendation of “Buy” from the twenty-two analysts that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have issued a buy rating on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $554.64.

Several brokerages have commented on ISRG. Cantor Fitzgerald reiterated a “buy” rating and set a $620.00 target price on shares of Intuitive Surgical in a research note on Friday, October 19th. Piper Jaffray Companies increased their target price on Intuitive Surgical from $613.00 to $625.00 and gave the company an “overweight” rating in a research note on Wednesday, October 31st. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $575.00 target price on shares of Intuitive Surgical in a research note on Friday, July 20th. Royal Bank of Canada set a $550.00 target price on Intuitive Surgical and gave the company a “hold” rating in a research note on Friday, July 20th. Finally, Stifel Nicolaus increased their target price on Intuitive Surgical from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, July 20th.

In other news, VP Marshall Mohr sold 7,500 shares of the stock in a transaction on Wednesday, October 31st. The stock was sold at an average price of $525.00, for a total transaction of $3,937,500.00. Following the transaction, the vice president now directly owns 17,321 shares of the company’s stock, valued at approximately $9,093,525. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Mark J. Rubash sold 150 shares of the firm’s stock in a transaction on Monday, August 27th. The stock was sold at an average price of $543.66, for a total value of $81,549.00. Following the completion of the transaction, the director now directly owns 4,116 shares in the company, valued at $2,237,704.56. The disclosure for this sale can be found here. Insiders have sold a total of 47,086 shares of company stock worth $24,023,337 over the last three months. Insiders own 2.20% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. CENTRAL TRUST Co increased its stake in Intuitive Surgical by 26.4% in the 3rd quarter. CENTRAL TRUST Co now owns 460 shares of the medical equipment provider’s stock worth $264,000 after buying an additional 96 shares in the last quarter. Wedbush Securities Inc. increased its stake in Intuitive Surgical by 1.4% in the 2nd quarter. Wedbush Securities Inc. now owns 7,086 shares of the medical equipment provider’s stock worth $3,391,000 after buying an additional 98 shares in the last quarter. Securian Asset Management Inc increased its stake in Intuitive Surgical by 0.9% in the 2nd quarter. Securian Asset Management Inc now owns 11,795 shares of the medical equipment provider’s stock worth $5,644,000 after buying an additional 100 shares in the last quarter. Sun Life Financial INC increased its stake in Intuitive Surgical by 59.9% in the 2nd quarter. Sun Life Financial INC now owns 307 shares of the medical equipment provider’s stock worth $147,000 after buying an additional 115 shares in the last quarter. Finally, Envestnet Asset Management Inc. increased its stake in Intuitive Surgical by 2.8% in the 2nd quarter. Envestnet Asset Management Inc. now owns 4,229 shares of the medical equipment provider’s stock worth $2,022,000 after buying an additional 117 shares in the last quarter. 84.16% of the stock is currently owned by institutional investors.

Shares of Intuitive Surgical stock traded down $12.28 during midday trading on Monday, hitting $503.94. The company had a trading volume of 28,653 shares, compared to its average volume of 1,133,923. The company has a market capitalization of $58.95 billion, a P/E ratio of 70.09, a PEG ratio of 3.47 and a beta of 1.02. Intuitive Surgical has a 52-week low of $359.75 and a 52-week high of $581.12.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 18th. The medical equipment provider reported $2.83 earnings per share for the quarter, topping the consensus estimate of $2.66 by $0.17. The company had revenue of $920.90 million for the quarter, compared to the consensus estimate of $916.22 million. Intuitive Surgical had a return on equity of 18.79% and a net margin of 22.31%. The firm’s quarterly revenue was up 14.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.77 EPS. Research analysts predict that Intuitive Surgical will post 9.52 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Read More: The risks of owning bonds

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply